Yi Han

发表

Initiation of GnRH agonist treatment on 3–5 days postoperatively in endometriosis patients: a randomized controlled trial

S. Zou, Q. Long, Lili Gong, 2015, Journal of clinical pharmacology.

Cost-effectiveness of sunitinib as second-line treatment for gastrointestinal stromal tumor in the People’s Republic of China

Yan Wang, M. Huang, Juanjuan Zhang, 2017 .

Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China

Yi Han, Congling Gu, Hui Huang, 2022, Advances in Therapy.

Cost-effectiveness analysis of rasburicase over standard of care for the prevention and treatment of tumor lysis syndrome in children with hematologic malignancies in China

Shaoyan Hu, Yi Han, X. Yao, 2019, Journal of medical economics.

Treatment adherence and persistence with long-acting somatostatin analog therapy for the treatment of acromegaly: a retrospective analysis

Yi Han, M. Gurel, A. Stevens, 2017, BMC Pharmacology and Toxicology.

Treatment adherence and persistence with long-acting somatostatin analog therapy for the treatment of acromegaly: a retrospective analysis

D. Cox, Yi Han, M. Gurel, 2017, BMC Pharmacology and Toxicology.

The budget impact of using enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg to prevent recurrent cardiovascular events

J. Tursi, D. Schofield, J. Fort, 2017, Journal of medical economics.

A mixed treatment comparison to compare the efficacy and safety of botulinum toxin treatments for cervical dystonia

Z. Mari, R. Hauser, K. Dashtipour, 2016, Journal of Neurology.

Clinical Benefits and Cost-Effectiveness of Moxifloxacin as Initial Treatment for Community-Acquired Pneumonia: A Meta-Analysis and Economic Evaluation.

J. Xuan, Yi Han, Liping Chen, 2021, Clinical therapeutics.

Cost-Effectiveness Analysis of the Application of a Porcine-Derived Fibrin Sealant for the Treatment of Cerebrospinal Fluid Leak in China.

Jie Zhao, Shuzhang Du, Yi Han, 2022, Clinical Therapeutics.

Oral continuous combined 0.5 mg estradiol valerate and 5 mg dydrogesterone as daily add-back therapy during post-operative GnRH agonist treatment for endometriosis in Chinese women.

S. Zou, Q. Long, Shao-fen Zhang, 2013, International journal of clinical and experimental medicine.

Standing and Supine Blood Pressure Outcomes Associated With Droxidopa and Midodrine in Patients With Neurogenic Orthostatic Hypotension: A Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials

R. Hauser, Jonathan Tang, K. Dashtipour, 2018, The Annals of pharmacotherapy.